OT The "Trickle Portfolio" was a thread with an actively managed portfolio that focused on biotech tool/reagent companies benefitting from "trickle" down spending of pharma and biotech companies. Rick coined the term, but I started the thread and managed the portfolio, which did modestly well for a while, then sank to around break-even. I think Trickle would be modestly but noticeably positive now were it still around, but the portfolio went bye-bye when SI decided to axe portfolios a few years back. At that time, it held good sized chunks of Bruker Daltonics (as it was then called) and Caliper, which would be the main drivers of the roughly projected present day performance. I think it had some shares of Xenogen, too, which Caliper later munched. It might have had a bit of PKI, can't remember. I did follow it and trade in & out of it for the portfolio. Ditto Waters and Sigma-Aldrich. Portfolios are back, but SI did not archive the old ones, & I had insufficient interest in starting over. The thread, though not very active, still exists:
Subject 37269
Edit: It had some QGEN, which would probably be a bit positive, and IVGN, which I believe was munched by Advanced Biosystems, which trickle also held. AFFX might have been a drag, though.
Cheers, Tuck |
